Healthcare - Medical - Devices - NASDAQ - US
$ 0.895
-5.78 %
$ 48.9 M
Market Cap
-2.49
P/E
CASH FLOW STATEMENT
-21.7 M
OPERATING CASH FLOW
-936 K
INVESTING CASH FLOW
14.5 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cytosorbents Corporation
| Net Income | -28.5 M |
| Depreciation & Amortization | 2.03 M |
| Capital Expenditures | -936 K |
| Stock-Based Compensation | 3.7 M |
| Change in Working Capital | 2.36 M |
| Others | -132 K |
| Free Cash Flow | -22.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | May-2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||
| Net Income | (28.5) | (32.8) | (24.6) | (7.8) | (19.3) | (17.2) | (8.5) | (11.9) | (8.1) | (9.3) | (4.7) | (3.7) | (5.5) | (2.9) | (2.7) | (3.0) | (3.4) | (7.7) | 80 K |
| Depreciation & Amortization | 2.0 | 1.1 | 1.1 | 0.7 | 0.6 | 0.4 | 0.2 | 0.2 | 0.1 | 65.5 K | 64.4 K | 54.6 K | 39.2 K | 17.8 K | 51.7 K | 0.1 | 0.2 | 1.3 | 10 K |
| Deferred Income Tax | 0 | 0 | 0 | (2.7) | 0.4 | 0.8 | (1.5) | 0.6 | 0.4 | 2.1 | 65.5 K | 63.1 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 3.7 | 3.8 | 6.2 | 4.7 | 2.8 | 0 | 3.3 | 2.8 | 0.4 | 0.7 | 65.5 K | 63.1 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | (1.2) | 3.2 | 2.6 | 0.3 | 0.1 | 0.7 | 82.1 K | 30.5 K | (1.3) | 0.4 | 0.8 | 0.5 | 1.8 | 0.2 | 0.3 | 0.4 | 0.9 | 3.5 | 100 K |
| Change in Working Capital | 2.4 | (3.6) | 0.6 | (0.8) | (1.5) | (0.9) | (0.2) | 1.7 | (0.4) | (0.6) | 0.3 | (0.5) | (0.2) | 0.2 | (0.2) | 0.1 | (0.3) | 63.3 K | 80 K |
| Cash From Operations | (21.7) | (28.2) | (14.0) | (5.6) | (16.8) | (10.8) | (6.5) | (6.7) | (9.0) | (6.7) | (3.5) | (3.6) | (3.8) | (2.5) | (2.7) | (2.4) | (2.6) | (2.8) | 50 K |
| INVESTING CASH FLOW | |||||||||||||||||||
| Capital Expenditures | (0.9) | (6.5) | (4.3) | (1.7) | (1.5) | (1.5) | (1.7) | (0.6) | (0.6) | (0.4) | (0.2) | 38.8 K | 52.5 K | (0.2) | 14.3 K | 22.1 K | 33.7 K | 64.9 K | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.2 | (0.2) | (1.9) | 0 | 0 | 0 | 0 | 0.2 | (0.2) | 0 | 0 | 0 |
| Cash From Investing Activities | (0.9) | (6.5) | (4.3) | (1.7) | (1.5) | (1.5) | (1.7) | 1.6 | (0.9) | (2.3) | (0.2) | 38.8 K | 52.5 K | (0.2) | 0.2 | (0.2) | 33.7 K | 64.9 K | 0 |
| FINANCING CASH FLOW | |||||||||||||||||||
| Common Stock Repurchased | 0 | 40.4 K | 90 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 5.0 | 0 | (15.0) | 5.0 | 0 | 5.0 | 5.0 | 0 | 0 | 1.8 | 0.7 | 1.2 | 1.3 | 0 | 0.2 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | (0.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.7) | 0 | (0.8) | 0 | 0 |
| Other Financing Activities | 0.2 | 40.4 K | 0.7 | 1.1 | 2.5 | 3.3 | 1.8 | 64.2 K | 2.1 | 0.3 | 2.4 | 10.6 K | 5.14 K | 0 | 0 | 4.9 | 0 | 0 | 40 K |
| Cash From Financing Activities | 14.5 | 5.0 | 0.7 | 66.3 | 8.2 | 17.5 | 20.1 | 5.1 | 11.6 | 10.0 | 4.2 | 4.2 | 4.0 | 2.1 | 1.3 | 5.1 | (0.8) | 5.1 | 40 K |
| CHANGE IN CASH | |||||||||||||||||||
| Net Change In Cash | (8.2) | (30.0) | (17.6) | 59.2 | (10.1) | 5.0 | 12.1 | 71.7 K | 1.7 | 1.4 | 0.5 | 0.5 | 0.1 | (0.5) | (1.2) | 2.5 | (2.7) | 2.2 | 20 K |
| FREE CASH FLOW | |||||||||||||||||||
| Free Cash Flow | (22.6) | (34.7) | (18.3) | (7.3) | (18.3) | (12.4) | (8.1) | (7.3) | (9.7) | (7.0) | (3.7) | (3.7) | (3.9) | (2.6) | (2.7) | (2.4) | (2.7) | (2.9) | 50 K |